NCT04837456

Brief Summary

The aim is to determine the outcomes of calorie-restricted diet and exercise intervention; libitum diet and waiting list control; early arthroscopic partial meniscectomy(APM) or delayed APM effect on MetS patients with Degenerate menisucus lesions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
189

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

March 6, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 8, 2021

Completed
Last Updated

April 8, 2021

Status Verified

April 1, 2021

Enrollment Period

2.8 years

First QC Date

March 6, 2021

Last Update Submit

April 7, 2021

Conditions

Keywords

Metabolic Syndromedegenerate meniscus lesionsCalorie restricted dietexercisearthroscopic partial meniscectomy

Outcome Measures

Primary Outcomes (21)

  • Knee KOOS4

    the Knee injury and Osteoarthritis Outcome Score (KOOS) holds five subscales: (1) Pain (9 items); (2) other Symptoms (7 items); (3) Activities of Daily Living (ADL, 17 items); (4) Sport and Recreation function (Sport/Rec, 5 items); and (5) knee-related Quality of Life (QoL, 4 items). Each subscale is scored separately from zero (extreme knee problems) to 100 (no knee problems) life (KOOs 4 ) were assessed.One of the most frequently-used knee-specific PROMs is the Knee injury and Osteoarthritis Outcome Score (KOOS) which was developed for adults who have knee OA or knee injuries.KOOS holds five subscales: (1) Pain (9 items); (2) other Symptoms (7 items); (3) Activities of Daily Living (ADL, 17 items); (4) Sport and Recreation function (Sport/Rec, 5 items); and (5) knee-related Quality of Life (QoL, 4 items). Each subscale is scored separately from zero (extreme knee problems) to 100 (no knee problems)

    up to 12 months

  • the scale of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    the WOMAC score is a disease-specific self-report multidimensional questionnare assesing pain, siffness, and physical functional disability.WOMAC scores range from 0 to 100, with higher scores indicating worse physical function.

    up to 12 months

  • The International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC).

    The IKDC is a questionnaire that has high reliability and validity for patients with a meniscal tear. The questionnaire contains 18 items scored in 1 of 3 ways: 11-point Likert scale, 5-point Likert scale, or dichotomous yes or no. After the participant completes the questionnaire, the scores are summed, and the total score is transformed to a value on a scale of 0 to 100, with 100 representing the highest knee function.

    up to 12 months

  • The WOMET score

    The WOMET is a meniscus-specific health-related quality-of-life instrument, validated especially for patients with a degenerative meniscal tear.The Western Ontario Meniscal Evaluation Tool (WOMET) contains 16 items addressing three domains: 9 items ad-dressing physical symptoms; 4 items addressing disabilities with regard to sports, recreation, work, and lifestyle; and 3 items addressing emotions. The score indicates the percentage of a normal score; therefore, 100 is the best possi- ble score, and 0 is the worst possible score.

    up to 12 months

  • height

    height in meters

    up to 12 months

  • weight

    weight in kilograms

    up to 12 months

  • BMI

    BMI, calculated as weight in kilograms divided by height in meters squaredBMI in kg/m\^2

    up to 12 months

  • waist circumstance

    waist circumstance in centimeter

    up to 12 months

  • Kellgren-Lawrence grade

    A Kellgren-Lawrence grade of 0 indicates no osteoarthritis, a grade of 1 with questionable osteophyte indicates possible osteoarthritis; a grade of 2 with definite osteophyte and no joint-space narrowing indicates mild osteoarthritis, a grade of 3 with ≤50% joint-space narrowing or a grade of 4 with\>50% joint-space narrowing indicates severe osteoarthritis were excluded.

    up to 12 months

  • systolic blood pressure

    systolic blood pressure in mm Hg

    up to 12 months

  • diastolic blood pressure

    diastolic blood pressure in mm Hg

    up to 12 months

  • triglyceride

    triglyceride in mmol/L

    up to 12 months

  • HDL-C

    high-density lipoprotein cholesterol in mmol/L

    up to 12 months

  • LDL-C

    low-density lipoprotein cholesterol in mmol/L

    up to 12 months

  • fast blood glucose

    fast blood glucose in mmol/L

    up to 12 months

  • total Cholesterol

    total Cholesterol in mmol/L

    up to 12 months

  • β-2 microglobulin

    β-2 microglobulin in mg/L

    up to 12 months

  • diabetes history

    diabetes history

    up to 12 months

  • cardio vascular disease history

    cardio vascular disease history

    up to 12 months

  • hypertension history

    hypertension history

    up to 12 months

  • Lysholm knee score

    The Lysholm knee score is based on an eight-item questionnaire designed to evaluate knee function and symptoms in activities of daily living. Scores range from 0 to 100; higher scores indicate less severe symptoms.

    up to 12 months

Study Arms (4)

Calorie restricted diet and excecise intervention

EXPERIMENTAL

a balanced diet that provided an energy deficit of 800 kcal/day from their daily energy requirement \[36\]. Macronutrient content of low caloric diet, expressed as percentage of ingested energy with carbohydrates 45-65%; fat 20-35%; and protein 10- 35%\[36\].Each session was approximately 150 minutes one week for six months and consisted of aerobic exercises, resistance training, and exercises to improve flexibility and balance.

Dietary Supplement: Calorie restricted diet and exercise intervention

libitum diet and waiting list control group

EXPERIMENTAL

participants then underwent a calorie of 2000 calorie above based on libitum free diets recommended to adults and normal physical activity without exercise during the program.

Procedure: libitum diet and waiting list control group

Early APM group

EXPERIMENTAL

Early APM group participants received APM with syndrome within 3 to 6 months

Procedure: Early arthroscopic partial menisectomy group

delayed APM group recruit participants with symptoms lasting for more than 6 months

EXPERIMENTAL

delayed APM group recruit participants with symptoms lasting for more than 6 months

Procedure: delayed APM group recruit participants with symptoms lasting for more than 6 months

Interventions

the calorie restricted diet were prescribed a balanced diet that provided an energy deficit of 800 kcal/day from their daily energy requirement.Macronutrient content of low caloric diet, expressed as percentage of ingested energy with carbohydrates 45-65%; fat 20-35%; and protein 10- 35%\[36\]. Participants were guided by a dietitian for adjustments of their caloric intake weekly for six months.Participants performed 1 or 2 sets at a resistance of approximately 65% of their one-repetition maximum, with 8 to 12 repetitions of each exercise; they gradually increased the intensity to 2 to 3 sets at a resistance of approximately 80% of their one-repetition maximum, with 6 to 8 repetitions of each exercise.

Calorie restricted diet and excecise intervention

libitum diet and waiting list control group, participants then underwent a calorie of 2000 calorie above based on libitum free diets recommended to adults and normal physical activity without exercise during the program.

libitum diet and waiting list control group

Early APM group participants received APM with syndrome within 3 to 6 months

Early APM group

delayed APM group recruit participants with symptoms lasting for more than 6 months

delayed APM group recruit participants with symptoms lasting for more than 6 months

Eligibility Criteria

Age35 Years - 70 Years
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be age between 35 and 70 years old;
  • Clinical diagnosis of metabolic syndrome;
  • Clinical diagnosis of 3 grade degneration meniscus leisons;

You may not qualify if:

  • Must be able to have no acute knee injury such as car crash or acute sports injury;
  • Must be able to have no knee surgeries history;
  • Must be able to have no rheumatoid arthritis or serious knee osteoarthritis with deformity;
  • Must be able to have no contraindications to MRI;
  • Must be able to have no severe cardiopulmonary disease;
  • Must be able to have no musculoskeletal or neuromuscular impairments ;
  • Must be able to have good visual, hearing, or cognitive;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Affiliated Hospital of Jinzhou Medical University

Jinzhou, Liaoning, 121000, China

Location

MeSH Terms

Conditions

Metabolic SyndromeMotor Activity

Interventions

Caloric Restriction

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesBehavior

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsEnergy IntakeDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Hongyu Wang, Doctor

    The First People's Hospital of Jingzhou

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
chief residents

Study Record Dates

First Submitted

March 6, 2021

First Posted

April 8, 2021

Study Start

June 1, 2017

Primary Completion

March 1, 2020

Study Completion

March 1, 2021

Last Updated

April 8, 2021

Record last verified: 2021-04

Locations